Y.D. More Investments LTD Astrazeneca PLC Transaction History

Y.D. More Investments LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$64.85 - $71.7 $26,523 - $29,325	-409 Reduced 31.25%	900 $60.9 Million
Q2 2023 Jul 12, 2023	SELL	$69.91 - $75.81 $160,793 - $174,363	-2,300 Reduced 63.73%	1,309 $93.7 Million
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $202,080 - $229,119	-3,200 Reduced 47.0%	3,609 $251 Million
Q4 2022 Feb 06, 2023	BUY	$54.21 - $70.44 $369,115 - $479,625	6,809 New	6,809 $464 Million

1,339

478M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $224B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Y.D. More Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Y.D. More Investments LTD with notifications on news.